All Stories

  1. Neuroprotective Effect of the Combination of Citicoline and CoQ10 in a Mouse Model of Ocular Hypertension
  2. Consequences of Early Maternal Deprivation on Neuroinflammation and Mitochondrial Dynamics in the Central Nervous System of Male and Female Rats
  3. Cilastatin as a Potential Anti-Inflammatory and Neuroprotective Treatment in the Management of Glaucoma
  4. Upregulation of TLR4/MyD88 pathway in alcohol-induced Wernicke’s encephalopathy: Findings in preclinical models and in a postmortem human case
  5. Is Saffron Able to Prevent the Dysregulation of Retinal Cytokines Induced by Ocular Hypertension in Mice?
  6. Cerebellar and cortical TLR4 activation and behavioral impairments in Wernicke-Korsakoff Syndrome: Pharmacological effects of oleoylethanolamide
  7. Neuronal and glial region dependent changes in female mice from a model of premature aging
  8. Retinal Molecular Changes Are Associated with Neuroinflammation and Loss of RGCs in an Experimental Model of Glaucoma
  9. Abstinent patients with alcohol use disorders show an altered plasma cytokine profile: Identification of both interleukin 6 and interleukin 17A as potential biomarkers of consumption and comorbid liver and pancreatic diseases
  10. Towards a consensus on developmental regression
  11. Commentary on “Rett syndrome before regression: A time window of overlooked opportunities for diagnosis and intervention” by Cosentino et al.
  12. Social stress during adolescence activates long-term microglia inflammation insult in reward processing nuclei
  13. Probiotics in digestive, emotional, and pain-related disorders
  14. Long-Term Effects of Intermittent Adolescent Alcohol Exposure in Male and Female Rats
  15. Evaluation of plasma cytokines in patients with cocaine use disorders in abstinence identifies transforming growth factor alpha (TGFα) as a potential biomarker of consumption and dual diagnosis
  16. Sex-dependent influence of chronic mild stress (CMS) on voluntary alcohol consumption; study of neurobiological consequences
  17. Blockage of neonatal leptin signaling induces changes in the hypothalamus associated with delayed pubertal onset and modifications in neuropeptide expression during adulthood in male rats
  18. Effects of Adolescent Intermittent Alcohol Exposure on the Expression of Endocannabinoid Signaling-Related Proteins in the Spleen of Young Adult Rats
  19. Potential Therapeutic Value of a Novel FAAH Inhibitor for the Treatment of Anxiety
  20. The maternal deprivation animal model revisited
  21. Early Maternal Deprivation Enhances Voluntary Alcohol Intake Induced by Exposure to Stressful Events Later in Life
  22. Disrupted Circadian Rhythm as a Common Player in Developmental Models of Neuropsychiatric Disorders
  23. Consequences of early life stress on the expression of endocannabinoid-related genes in the rat brain
  24. Early maternal deprivation immunologically primes hippocampal synapses by redistributing interleukin-1 receptor type I in a sex dependent manner
  25. Prenatal corticosterone and adolescent URB597 administration modulate emotionality and CB1 receptor expression in mice
  26. Sex-Dependent Psychoneuroendocrine Effects of THC and MDMA in an Animal Model of Adolescent Drug Consumption
  27. Emotional, endocrine and brain anandamide response to social challenge in infant male rats
  28. Maternal Deprivation Is Associated With Sex-Dependent Alterations in Nociceptive Behavior and Neuroinflammatory Mediators in the Rat Following Peripheral Nerve Injury
  29. Sex-dependent changes in brain CB1R expression and functionality and immune CB2R expression as a consequence of maternal deprivation and adolescent cocaine exposure
  30. Maternal deprivation effects on brain plasticity and recognition memory in adolescent male and female rats
  31. The role of the endocannabinoid system in eating disorders
  32. Neurobehavioral and metabolic long-term consequences of neonatal maternal deprivation stress and adolescent olanzapine treatment in male and female rats
  33. A Comparative, Developmental, and Clinical Perspective of Neurobehavioral Sexual Dimorphisms
  34. Analyzing the effects of a single episode of neonatal maternal deprivation on metabolite profiles in rat brain: a proton nuclear magnetic resonance spectroscopy study
  35. The endocannabinoid system and emotional processing: pathophysiology and therapeutic potential
  36. Differential response to specific 5-Ht(7) versus whole-serotonergic drugs in rat forebrains: A phMRI study
  37. Framework for sex differences in adolescent neurobiology: A focus on cannabinoids
  38. Neurobehavioral adaptations to methylphenidate: The issue of early adolescent exposure
  39. Passing the knife edge in adolescence: Brain pruning and specification of individual lines of development
  40. Consumo de cannabis y neurodesarrollo: ¿por qué son relevantes las diferencias de género?
  41. The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives
  42. Social encounter with a novel partner in adolescent rats: Activation of the central endocannabinoid system
  43. Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects
  44. Critical Age Windows for Neurodevelopmental Psychiatric Disorders: Evidence from Animal Models
  45. The Critical Role of the Endocannabinoid System in Emotional Homeostasis: Avoiding Excess and Deficiencies
  46. Detrimental psychophysiological effects of early maternal deprivation in adolescent and adult rodents: Altered responses to cannabinoid exposure
  47. Methylphenidate to adolescent rats drives enduring changes of accumbal Htr7 expression: implications for impulsive behavior and neuronal morphology
  48. Long-term consequences of URB597 administration during adolescence on cannabinoid CB1 receptor binding in brain areas
  49. Implicación funcional del sistema cannabinoide endógeno en la homeostasis emocional
  50. Peculiar response to methylphenidate in adolescent compared to adult rats: a phMRI study
  51. Neuronal and glial alterations in the cerebellar cortex of maternally deprived rats: Gender differences and modulatory effects of two inhibitors of endocannabinoid inactivation
  52. Gender-dependent cellular and biochemical effects of maternal deprivation on the hippocampus of neonatal rats: A possible role for the endocannabinoid system
  53. Effects of adolescent nicotine and SR 147778 (Surinabant) administration on food intake, somatic growth and metabolic parameters in rats
  54. The role of the hippocampus in mediating emotional responses to nicotine and cannabinoids: a possible neural substrate for functional interactions
  55. Early maternal deprivation and neonatal single administration with a cannabinoid agonist induce long-term sex-dependent psychoimmunoendocrine effects in adolescent rats
  56. Influence of Aging and Enriched Environment on Motor Activity and Emotional Responses in Mice
  57. Enhancement of endocannabinoid signalling during adolescence: Modulation of impulsivity and long-term consequences on metabolic brain parameters in early maternally deprived rats
  58. Subchronic nicotine exposure in adolescence induces long-term effects on hippocampal and striatal cannabinoid-CB1 and mu-opioid receptors in rats
  59. Endocannabinoid System and Synaptic Plasticity: Implications for Emotional Responses
  60. Adolescent exposure to nicotine modifies acute functional responses to cannabinoid agonists in rats
  61. Nicotine and cannabinoids: Parallels, contrasts and interactions
  62. Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods
  63. The κ-opioid receptor is involved in the stimulating effect of nicotine on adrenocortical activity but not in nicotine induced anxiety
  64. Endocannabinoid system and stress and anxiety responses
  65. Behavioral, endocrine and immunological characteristics of a murine model of premature aging
  66. Functional responses to the cannabinoid agonist WIN 55,212-2 in neonatal rats of both genders: influence of weaning
  67. Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test
  68. Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats
  69. Chronic treatment with CP 55,940 during the peri-adolescent period differentially affects the behavioural responses of male and female rats in adulthood
  70. Do different mechanisms underlie two anxiogenic effects of systemic nicotine?
  71. Involvement of the κ-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats